Earnings & Reporting

Fulgent Genetics reports revenue growth but faces a pivotal year with a major customer loss, betting its future on strategic acquisitions and a promising drug pipeline.

A major Q1 loss, driven by massive restructuring costs, marks a pivotal moment as the bank sheds retail to focus on commercial under a new owner.

More men are swapping sun loungers for stress management. A new survey reveals a cultural shift toward 'reset' holidays. What does this mean for travel?

The Mexican pharma giant saw sales fall in 2025 but improved margins, strategically clearing inventory and reinvesting savings for a planned 2026 recovery.

The infrastructure giant posted a 12.2% EBITDA jump fueled by North American highways and a record construction backlog, solidifying its US-focused strategy.

The Illinois-based bank crushed Q4 estimates with a 62.5% profit jump, outperforming sector trends through strong interest income and strategic growth.

High Liner Foods posts higher Q4 sales but faces shrinking profits from tariffs and acquisition costs. Can new products and efficiencies turn the tide?

Morgan Stanley Direct Lending Fund reports lower Q4 NII and cuts its dividend, while launching a new joint venture to spur long-term strategic growth.

Surpassing $2B in sales and achieving sustained profitability, The RealReal's 2025 results signal a new era for the luxury resale giant. But can it last?

The safety solutions leader adds a top CFO and CEO to its board, a strategic move to bolster financial oversight and drive growth amid record performance.

The AI semiconductor firm posts 37% annual revenue growth and a return to non-GAAP profit, proving its strategic pivot to intelligent edge devices is a success.

The 3M spin-off navigates a transformative year, posting strong organic growth driven by MedSurg and Dental, despite a reported sales dip from divestitures.

The ad tech firm's stock surged on a strong Q4, but a full-year loss highlights its high-stakes pivot to AI and CTV to fuel future growth.

Atlanta's Ameris Bank leaps to #15 on Forbes' Best Banks list, the largest by assets in the top tier. What's behind its impressive growth?

New research reveals a massive trust gap in healthcare AI as overall confidence drops. Why are users believers while the vast majority of Americans remain wary?

The Daytime Dining leader heads to three major investor conferences with a record of rapid expansion, but faces questions on traffic, inflation, and its 2026 outlook.

Love's Travel Stops overhauls its loyalty program, unifying rewards for all drivers in a digital-first push to win the battle for the roadside.

As AOUT prepares its Q3 results, investors seek signs of resilience in a tough market. Can its innovation pipeline offset cautious consumer spending?

Luckin Coffee posted massive 2025 revenue growth and surpassed 31,000 stores, but a sharp Q4 drop in profitability has investors questioning the cost of its aggressive expansion.

Palmer Square Capital BDC reports a drop in 2025 income and asset value but highlights rock-solid credit quality and an optimistic outlook for 2026.